Edwards CEO Mussallem announces stock plans | Personnel Moves

May 7, 2012 by MassDevice staff

Edwards Lifesciences chairman & CEO Michael Mussallem will in May begin exercising his stock options under SEC rule 10b5-1; also SRS Medical promotes Lee Brody to the corner office; Advanced Cardiac Therapeutics shuffles the deck, builds its hand to support commercialization; CardioKinetix names Maria Sainz president & CEO; Zeltiq interim president & CEO Mark Foley to receive $50k per month; and more.


 Edwards' CEO Mussallem exercises stock options

Get the complete picture with a MassDevice Plus membership. Registered users can login here.